×

Food and Staples Retailing Drug Retail

  • Drug Price Relief Act battle

    Debating whether California voters should pass Proposition 61, the Drug Price Relief Act, with Scott Gottlieb, physician and American Enterprise Institute Resident Fellow, and Zeke Emanuel, University of Pennsylvania vice provost for global initiatives.

  • Cramer: The drug wholesale price war has officially begun — steer clear

    Jim Cramer addressed the stunning decline in McKesson, and got to the bottom of what triggered the sudden fall in the stock.

  • Washington's next biotech target?

    CNBC's Meg Tirrell reports the latest surrounding Ariad Pharmaceuticals and the company's drug price hike.

  • Ariad cancer drug pricing under congressional scrutiny

    CNBC's Meg Tirrell reports the latest on a tweet sent by Sen. Bernie Sanders about Ariad Pharmaceuticals' cancer drug pricing.

  • *Reports 4th- qtr adj. profit of $1.07/ shr vs est. Forecasts FY adj. profit of $4.85- $5.20/ shr, includes Rite Aid. The No. 1 U.S. drugstore operator by store count said it expected to divest the 500-1,000 stores it needs to shed to win approval for the $9.4 billion acquisition by the end of 2016, and now expects the deal to close on Jan. 27.

  • A Walgreens store in Boston.

    Walgreens Boots Alliance reported a jump in quarterly profit and said it now expected its acquisition of Rite Aid Corp to close in early 2017.

  • *Reports 4th- qtr adj. profit of $1.07/ shr vs est. *Extends end date of merger to Jan. 27. Oct 20- Drugstore operator Walgreens Boots Alliance Inc reported a better-than-expected quarterly profit, helped by cost cutting, and said it now expected its acquisition of Rite Aid Corp to close on Jan. 27, three months later than planned.

  • Kaine: Can't imagine savvy financial person prefers Trump

    Democratic vice presidential candidate Tim Kaine discusses Donald Trump's tax plan and Hillary Clinton's Catholic comments in the Wikileaks emails.

  • Kaine: Estate tax is something we should maintain

    Democratic vice presidential candidate Tim Kaine discusses lowering drug prices, Wall Street and regulation and estate taxes.

  • California's drug pricing bill

    CNBC's Meg Tirrell reports the latest on the controversy surrounding the California Drug Price Relief Act including the Bernie Sanders' support for the proposition.

  • Copay assistance: Doing more harm than good?

    Dr. Peter Bach, Memorial Sloan Kettering physician, discusses how copay assistance programs are actually causing drug prices to rise.

  • Copay assistance could raise drug costs

    CNBC's Meg Tirrell discusses implications surrounding co-pay assistance programs.

  • Humana sinks on medicare rating

    CNBC's Bertha Coombs reports the latest troubles in health care, including why shares of Humana are sinking.

  • Cramer: Drug stocks are dangerous until after the election. Here's why

    Jim Cramer says uncertainty surrounding a Democratic win for the White House puts drug stocks in the danger zone.

  • Pharma in government crosshairs: Who's next?

    David Maris, Wells Fargo Securities, discusses where he foresees trouble in the biotech sector, as well finding safety in these cases.

  • Illumina sinks on Q3 sales

    CNBC's Meg Tirrell reports the latest trouble in the biotech sector, specifically involving Illumina and Theranos.

  • War on cancer

    CNBC's Meg Tirrell reports on the moves in cancer drugmakers following the European Cancer Congress in Copenhagen. The "FMHR" traders weigh in.

  • Congressmen confirm Mylan overcharged Medicaid

    CNBC's Meg Tirrell reports the latest of the EpiPen controversy, including confirmation of Mylan overcharging Medicaid. CNBC senior markets contributor Mike Santoli and "Fast Money" trader Steve Grasso weigh in.

  • NEW YORK, Oct 3- A decade after JPMorgan Chase& Co said with great fanfare that it would make life easier for customers by putting its cash machines into Duane Reade drug stores in New York City and Walgreens stores in Florida, the big bank is retreating. The new message is the public start of a withdrawal that stems from an agreement the largest U.S. bank by assets made...

  • NEW YORK, Oct 3- A decade after JPMorgan Chase& Co said with great fanfare that it would make life easier for customers by putting its cash machines into Duane Reade drug stores in New York City and Walgreens stores in Florida, the big bank is retreating. The new message is the public start of a withdrawal that stems from an agreement the largest U.S. bank by assets made...